Product Description
Since last manyA years SaintroyA LifescienceA is leading manufacture, export andsupplier ofA Dactinomycin for InjectionA from Surat, Gujarat, India. Dactinomycin For Injection used to treat a number of types of cancer.
Tags: Dactinomycin for Injection manufacturer, Dactinomycin forInjection exporter, Dactinomycin for Injection supplier, and Dactinomycin forInjection, whogmp approved Dactinomycin for Injection manufacturer andsupplier, Dactinomycin for Injection distributor, Dactinomycin for Injection shipper,Dactinomycin for InjectionA 0.5 mgA Dactinomycin for Injection A 0.5 mgA supplier,Dactinomycin for Injection 0.5 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inA Gujarat, India.
Registration: Saintroy LifescienceA is interested inregistration of own brand or customer brands in ministryA of health of clientsA country and we also provide the products samples, COA, COPP, ACTorA CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export CountryA :Saintroy LifescienceA Dactinomycin forInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.A
Precise Dosage and AdministrationDactinomycin is formulated in a 500 mcg strength per vial and is intended for intravenous injection after proper reconstitution and dilution. Administration should occur under experienced medical supervision in a hospital, strictly adhering to guidelines to avoid extravasation and ensuring patient safety.
Comprehensive Safety and HandlingThis medication is manufactured under GMP standards, ensuring strict quality and safety protocols. Each vial is clearly labeled with batch number and expiry date. Special attention must be paid to storage requirements - a cool, dry environment helps preserve efficacy within its 2-year shelf life.
Indications and Targeted Therapeutic ApplicationDactinomycin for Injection is effective in treating various cancers, including Wilms tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular cancer, and gestational trophoblastic neoplasia, offering a targeted therapy for both children and adults as prescribed by an oncologist.
FAQ's of Dactinomycin for Injection:
Q: How should Dactinomycin for Injection 500 mcg be reconstituted and administered?
A: Reconstitute each single-use vial with Sterile Water for Injection following the dilution instructions provided in the product leaflet. After complete dissolution, administer intravenously in a hospital by a qualified health professional, taking precautions to prevent extravasation.
Q: What cancers is Dactinomycin for Injection indicated for?
A: This drug is indicated for the treatment of Wilms tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular cancer, and gestational trophoblastic neoplasia in both pediatric and adult patients as directed by a physician.
Q: When should Dactinomycin for Injection not be used?
A: Do not administer Dactinomycin to individuals with known hypersensitivity to dactinomycin. It must also not be used outside hospital settings or without a prescription, due to its toxicity.
Q: Where should Dactinomycin for Injection be stored for optimal stability?
A: Store the vials in a cool, dry place, away from direct light, and ensure they remain within their two-year shelf life as stated on the vial. Always check the expiry date before use.
Q: What precautions should healthcare providers observe during administration?
A: Healthcare professionals should strictly avoid extravasation and adhere to safety protocols. Use appropriate personal protective equipment and prepare the medication in a hospital pharmacy to minimize exposure risks.
Q: What is the typical benefit of using Dactinomycin for Injection in cancer patients?
A: Dactinomycin disrupts the growth and proliferation of cancer cells, making it a pivotal component in chemotherapy protocols for the indicated cancers, enhancing the potential for improved patient outcomes when administered appropriately.